Connection
John Tilford to Cost-Benefit Analysis
This is a "connection" page, showing publications John Tilford has written about Cost-Benefit Analysis.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.840 |
|
|
|
-
Tilford JM, Tarlan A. The Carer QALY Trap and Altruism in Economic Evaluations. Pharmacoeconomics. 2023 Dec; 41(12):1553-1555.
Score: 0.203
-
Tilford JM. Cost-effectiveness analysis and emergency medical services for children: issues and applications. Ambul Pediatr. 2002 Jul-Aug; 2(4 Suppl):330-6.
Score: 0.185
-
Ferguson A, Yates C, Tilford JM. Value-based insurance designs in the treatment of mental health disorders. Am J Manag Care. 2016 Jan 01; 22(1):e38-44.
Score: 0.118
-
Payakachat N, Ali MM, Tilford JM. Can The EQ-5D Detect Meaningful Change? A Systematic Review. Pharmacoeconomics. 2015 Nov; 33(11):1137-54.
Score: 0.117
-
Tilford JM, Grosse SD, Goodman AC, Li K. Labor market productivity costs for caregivers of children with spina bifida: a population-based analysis. Med Decis Making. 2009 Jan-Feb; 29(1):23-32.
Score: 0.071
-
Tilford JM, Aitken ME, Goodman AC, Adelson PD. Measuring the cost-effectiveness of technologic change in the treatment of pediatric traumatic brain injury. J Trauma. 2007 Dec; 63(6 Suppl):S113-20; discussion S121.
Score: 0.067
-
Tilford JM, Grosse SD, Robbins JM, Pyne JM, Cleves MA, Hobbs CA. Health state preference scores of children with spina bifida and their caregivers. Qual Life Res. 2005 May; 14(4):1087-98.
Score: 0.056
-
Payakachat N, Tilford JM, Kovacs E, Kuhlthau K. Autism spectrum disorders: a review of measures for clinical, health services and cost-effectiveness applications. Expert Rev Pharmacoecon Outcomes Res. 2012 Aug; 12(4):485-503.
Score: 0.023